Sr No. | Product Name | End use |
---|---|---|
1 | 1-[2-(2-Hydroxyethoxy)ethyl] piperazine (CAS 40018-26-6) |
Quetiapine Fumarate API |
2 | 2-(2-Chloroethoxy) ethanol (CAS 628-89-7) |
Quetiapine Fumarate API, Hydroxyzine HCl, Cetrizine HCl |
3 | 2-(Chloromethyl)-1, 3-dioxolane (CAS 2568-30-1) |
Doxofylline |
4 | 2-Chloroethylacetoacetate (CAS 609-15-4) |
Cimetidine API, Febuxostat API, Apixaban API |
5 | 2-Isobutyl thiazole (CAS 18640-74-9) |
- |
6 | 3-Amino-4-methyl-2-thiophene carboxylic acid methyl ester (CAS 85006-31-3) |
Intermediate for Articain API |
7 | 3-Fluorobenzenesulfonyl Chloride (CAS 701-27-9) |
Fexuprazone Intermediate |
8 | 4-Chlorobutyl benzene (CAS 4830-93-7) |
production of synthetic rubber, as a plasticizer |
9 | Amino acetaldehyde Dimethylacetal (CAS 22483-09-6) |
Dolutegravir Sodium |
10 | Ammonium 2-Furyl (methoxyimino) acetate (CAS 97148-39-5) |
Cefuroxime Axetil |
11 | Chloroacetaldehyde Dimethyl Acetal (CAS 97-97-2) |
Dolutegravir Sodium |
12 | Ethyl Nicotinate (CAS 614-18-6) |
Skin conditioning cosmetic Formulations |
13 | Methyl 5-(2, 4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate (CAS 1902955-29-6) |
Fexuprazone Intermediate |
14 | Methyl hydrazinecarbodithioate (CAS 5397-03-5) |
Inhibitor of the enzyme dihydrofolate reductase |
15 | Myosmine (Aq sol, ~ 50% w/w) (CAS 532-12-7) |
Nicotine |
16 | N, O-Dimethyl hydroxylamine Hydrochloride (CAS 6638-79-5) |
Weinreb Amide/Amine, Sarecyclene HCl |
17 | N-(n-Butyl)thiophosphoric triamide (NBPT) (CAS 94317-64-3) |
Urea Inhibitor |